Posted by psychobot5000 on January 31, 2010, at 16:31:46
In reply to Discontinued development of Eplivanserin, posted by NickCave on January 25, 2010, at 18:08:22
Truly depressing. Why the FDA doesn't want a non-addictive drug with a new(ish), selective mechanism of action to enter the insomnia market is beyond me, but it could have been useful for anxiety and depression also. Curse them.
> Sanofi discontinues development of insomnia drug Eplivanserin. I am really crushed about this. I think it would be the perfect drug to compliment my lexapro and bring me to full remission. looks like money might be the reason due to patent issues. It seems every new drug on the horizon that I am excited about has been delayed or cancelled. How come experimental AIDS drugs get rushed through the process, but depression drugs are continuously held up? Depression kills too, but most people don't look at it that way.
>
> http://patentcircle.blogspot.com/2010/01/sanofi-discontinued-development-of.html
>
>
poster:psychobot5000
thread:934972
URL: http://www.dr-bob.org/babble/20100122/msgs/935522.html